SINGAPORE (Oct 1): After its plans to go into asset management unravelled, New Silkroutes Group (NSG) turned its attention to becoming a healthcare player via a series of acquisitions and joint ventures.

As the market awaits meaningful contributions from these new healthcare ventures to come in, shares in the company have been declining steadily. Dr Goh Jin Hian, its CEO, has been increasing his stake in the company with a series of purchases from the open market over the past few months.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook